Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01755715
Other study ID # KILKE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2013
Est. completion date December 2018

Study information

Verified date March 2019
Source Helsinki University Central Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to compare, in a randomised, controlled and prospective fashion, initiation of intrauterine contraception (IUC) at about immediate (0 to 3 days) versus 2 to 4 weeks post medical abortion with regard to expulsions and use of contraception one year after abortion.


Recruitment information / eligibility

Status Completed
Enrollment 264
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age =18 years

- Planning medical abortion

- Planning LNG-IUD (Mirena) contraception

Exclusion Criteria:

- Pathological pregnancies or abnormality of the uterus or cervix

- Acute endometritis

Study Design


Related Conditions & MeSH terms

  • Contraception After Medical Abortion

Intervention

Procedure:
Immediate IUD insertion
Insertion of LNG-IUD (Mirena) (at the same day to 3 days) after expulsion of placenta.

Locations

Country Name City State
Finland Helsinki University Central Hospital, Dept Ob&Gyn Helsinki

Sponsors (1)

Lead Sponsor Collaborator
Riina Korjamo

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of expulsions Number of IUD expulsions 1 year
Primary Use of IUD 1 year
Secondary Bleeding profile 3 months
Secondary Repeat abortions 5 years